Activity-dependent neurotrophic factor: Structure-activity relationships of femtomolar-acting peptides

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 2, 1998, Pages 619-627

  Brenneman, Douglas E ^a   Hauser, Janet ^a   Neale, Elaine ^a   Rubinraut, Sara ^b   Fridkin, Mati ^b   Davidson, Ariane ^c   Gozes, Illana ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY DEPENDENT NEUROTROPHIC FACTOR; AMYLOID BETA PROTEIN; BAFILOMYCIN A1; N METHYL DEXTRO ASPARTIC ACID; NEUROTROPHIC FACTOR; TETRODOTOXIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GLIA CELL; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NEWBORN; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031809440     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Agoston DV, Eiden LE, Brenneman DE and Gozes I (1991) Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cultures. Mol Brain Res 10:235-240.
2. Bowman EJ, Siebers A and Altendorf (1988) Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 85:7972-7976.
3. Brenneman DE (1986) Role of electrical activity and trophic factors during cholinergic development in dissociated cultures. Can J Physiol Pharmacol 64:356-362.
4. Brenneman DE and Eiden LE (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA 83:1159-1162.
5. Brenneman DE, Eiden LE and Siegel RE (1985a) Neurotrophic action of VIP on spinal cord cultures. Peptides 6:suppl 2, 35-39.
6. Brenneman DE, Fitzgerald S and Litzinger MJ (1985b) Neuronal survival during electrical blockade is increased by 8-bromo cyclic adenosine 3′,5′ monophosphate. J Pharmacol Exp Ther 233:402-408.
7. Brenneman DE, Fitzgerald S and Nelson PG (1984) Interaction between trophic action and electrical activity in spinal cord cultures. Brain Res 317:211-217.
8. Brenneman DE and Gozes I (1996) A femtomolar-acting neuroprotective peptide [see comments]. J Clin Invest 97:2299-2307.
9. Brenneman DE, Hill JM, Glazner GW, Gozes I and Phillips TW (1995) Interleukin-1 alpha and vasoactive intestinal peptide: Enigmatic regulation of neuronal survival. Int J Dev Neurosci 13:187-200.
10. Brenneman DE, Neale EA, Foster GA, D'Autremont SW and Westbrook GL (1987) Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J Cell Biol 104:1603-1610.
11. Brenneman DE, Neale EA, Habig WH, Bowers LM and Nelson PG (1983) Developmental and neurochemical specificity of neuronal deficits produced by electrical impulse blockade in dissociated spinal cord cultures. Brain Res 285:13-27.
12. Brenneman DE, Nicol T, Warren D and Bowers LM (1990a) Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. J Neurosci Res 25:386-394.
13. Brenneman DE, Schultzberg M, Bartfai T and Gozes I (1992) Cytokine regulation of neuronal survival. J Neurochem. 58:454-460.
14. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR and Pert CB (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (Lond) 335:639-642.
15. Brenneman DE, Yu C and Nelson PG (1990b) Multi-determinate regulation of neuronal survival: Neuropeptides, excitatory amino acids and bioelectric activity. Int J Dev Neurosci 8:371-378.
16. 2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J Neurobiol 26:325-338.
17. Brown MS and Goldstein JL (1979) Receptor-mediated endocytosis: Insights from the lipoprotein receptor system. Proc Natl Acad Sci USA 76:3330-3337.
18. Cafe C, Torri C, Bertorelli L, Angeretti N, Lucca E, Forloni G and Marzatico F (1996) Oxidative stress after acute and chronic application of beta-amyloid fragment 25-35 in cortical cultures. Neurosci Lett 203:61-65.
19. Dibbern DA, Glazner GW, Gozes I, Brenneman DE and Hill JM (1997) Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor. J Clin Invest 99:2837-2841.
20. Festoff BW, Nelson JB and Brenneman DE (1996) Prevention of activity-dependent neuronal death: Vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin-1. J Neurobiol 30:255-266.
21. Galcheva-Gargova Z, Theroux SJ and Davis RJ (1995) The epidermal growth factor receptor is covalently linked to ubiquitin. Oncogene 11:2649-2655.
22. Goldstein JL, Andersen RG and Brown MS (1979) Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature (Lond) 279:679-685.
23. Gozes I, Bardea A, Reshef A, Zamostiano R, Zhukovsky S, Rubinraut S, Fridkin M and Brenneman DE (1996) Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci USA 93:427- 432.
24. Gozes I and Brenneman DE (1996) Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin? J Mol Neurosci 7:235-244.
25. Gozes I, Davidson A, Gozes Y, Mascolo R, Earth R, Warren D, Hauser J and Brenneman DE (1997) Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: Immunological and biological specificity. Brain Res Dev Brain Res 99:167-175.
26. Gozes I, Lilling G, Glazer R, Ticher A, Ashkenazi IE, Davidson A, Rubinraut S, Fridkin M and Brenneman DE (1995) Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J Pharmacol Exp Ther 273:161- 167.
27. Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M and Brenneman DE (1991) An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J Pharmacol Exp Ther 257:959-966.
28. Gressens P, Hill JM, Gozes I, Fridkin M and Brenneman DE (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature (Lond) 362:155-158.
29. Hill JM, Mervis RF, Avidor R, Moody TW and Brenneman DE (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 603:222-233.
30. Kinoshita K, Waritani T, Noto M, Takizawa K, Minemoto Y, Nishikawa A, Ohkuma S and Nishikawa Y (1996) Bafilomycin A1 induces apoptosis in PC12 cells independently of intracellular pH. FEBS Lett 398:61-66.
31. Korherr C, Hofmeister R, Wesche H and Falk W (1997) A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol 27: 262-267.
32. Longo FM, Manthorpe M, Xie YM and Varon S (1997) Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res 48:1-17.
33. Mark RJ, Blanc EM and Mattson MP (1996) Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol 12:211-224.
34. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147.
35. Matsumoto K, Wanaka A, Takatsuji K, Muramatsu H, Muramatsu T and Tohyama M (1994) A novel family of heparin-binding growth factors, pleiotrophin and midkine, is expressed in the developing rat cerebral cortex. Brain Res Dev Brain Res 79:229-241.
36. McCarthy KD and De Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
37. Mori S, Ronnstrand L, Claesson-Welsh L and Heldin CH (1994) A tyrosine residue in the juxtamembrane segment of the platelet-derived growth factor beta-receptor is critical for ligand-mediated endocytosis. J Biol Chem 269:4917-4921.
38. Multhaup G (1997) Amyloid precursor protein, copper and Alzheimer's disease. Biomed Pharmacother 51:105-111.
39. Paradis E, Douillard H, Koutroumanis M, Goodyer C and Leblanc A (1996) Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J Neurosci 16:7533-7539.
40. Prager D, Li HL, Amnesiac H and Melded S (1994) Human insulin-like growth factor I receptor internalization. Role of the juxta membrane domain. J Bill Chem 269:11934-11937.
41. Prehn JH, Bindokas VP, Jordan J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Thompson CB, Krajewski S, Reed JC and Miller RJ (1996) Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49:319-328.
42. Ransom BR and Holz RW (1977) Ionic determinants of excitability in cultured mouse dorsal root ganglion and spinal cord cells. Brain Res 136:445-453.
43. Romijn HJ, Van Huizen F and Wolters PS (1984) Towards an improved serum-free, chemically defined medium for long-term culturing of cerebral cortex tissue. Neurosci Biobehav Rev 8:301-334.
44. Said SI, Berisha HI and Pakbaz H (1996) Excitotoxicity in the lung: N-methyl-D- aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 93:4688-4692.
45. Schapira AH (1996) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 9:260-264.
46. Schmechel D, Marangos PJ, Zis AP, Brightman M and Goodwin FK (1978) Brain endolases as specific markers of neuronal and glial cells. Science 199:313-315.
47. Uchida Y and Ihara Y (1995) The N-terminal portion of growth inhibitory factor is sufficient for biological activity. J Bill Chem 270:3365-3369.
48. Vieira AV, Lamaze C and Schmid SL (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science (Wash DC) 274:2086-2089.
49. Yocum SA, Lopresti-Morrow LL, Gabel CA, Milici AJ and Mitchell PG (1995) Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis. Arch Biochem Biophys 316:827-835.